Designing drugs targeting “twin” cancer proteins
A drug candidate (pink) was found to bind to the pocket between the cancer-related protein CCNE1 (green) and its partner ...
A drug candidate (pink) was found to bind to the pocket between the cancer-related protein CCNE1 (green) and its partner ...
Susceptibility of SARS-CoV-2-nsp5T169Insp12V792I virus to nirmatrelvir and remdesivir in vitro. Credit: Natural communications (2024). DOI: 10.1038/s41467-024-51924-3 Two studies have found ...
Credit: Pixabay/CC0 Public Domain There are over 7,000 rare and undiagnosed diseases worldwide. Although each condition affects only a small ...
Wegovy, Mounjaro, Ozempic... These drugs are driving the pharmaceutical industry crazy and fueling the hopes of millions of patients suffering ...
Credit: Unsplash/CC0 Public Domain Two new drugs, the first capable of slowing the debilitating progression of Alzheimer's disease, are at ...
Characterization of paired aneuploid and pseudo-diploid clones. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-52176-x Two complementary studies conducted by Tel Aviv ...
Graphic summary. Credit: Cellular metabolism (2024). DOI: 10.1016/j.cmet.2024.07.023 To combat fatty liver disease, researchers are looking for every solution they ...
Ionizable analogues of fulvestrant were formulated into nanoparticles with cholesterol, DSPC and DMG-PEG (molar ratio 50:38.5:10:1.5) to encapsulate siRNA (FXNP). ...
A formamide modification (yellow) to a siRNA therapeutic agent (blue) prevents it from binding to non-targeted mRNA, allowing treatment with ...
Ben Lehner (left) and Fran Supek (right), co-corresponding authors of the study. Credit: Centre for Genomic Regulation A computer model ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press